<?xml version="1.0" encoding="UTF-8"?>
<p>In this case report we describe the use of kratom (
 <italic>Mitragyna speciosa</italic>), a plant used in traditional medicine in South-East Asia for its therapeutic benefits in self-managing opioid dependence and withdrawal, psychological disorders (e.g., anxiety and depression), and chronic pain (
 <xref rid="B13" ref-type="bibr">13</xref>, 
 <xref rid="B14" ref-type="bibr">14</xref>), and to successfully alleviate COVID-19 related symptoms. Kratom contains more than 40 alkaloids (
 <xref rid="B15" ref-type="bibr">15</xref>, 
 <xref rid="B16" ref-type="bibr">16</xref>), though the majority of its pharmacological properties appear to be related to two of the active compounds: mitragynine and its metabolite 7-hydroxymitragynine (
 <xref rid="B17" ref-type="bibr">17</xref>–
 <xref rid="B19" ref-type="bibr">19</xref>). Kratom is reported to have opioid and non-opioid like effects. In traditional settings in Malaysia and Thailand, rural folks traditionally use kratom as a remedy to treat common health maladies, and kratom consumption practice/tradition do not seem to cause any significant health problems (
 <xref rid="B20" ref-type="bibr">20</xref>–
 <xref rid="B22" ref-type="bibr">22</xref>).
</p>
